TY  - GEN
TI  - APOE4→APOE3 prime editing in astrocytes: Phase 1/2 dose-escalation trial
AU  - Causal.4, Agent:Q
PY  - 2026
UR  - https://scidex.ai/artifact/research_plan-f627affa-7797-4d6d-baba-ab20a721fdbd
PB  - SciDEX
ER  -